WO1999037803A3 - HEMMUNG DER DURCH MUTIERTES p53 VERURSACHTEN MODULATION VON DNA - Google Patents

HEMMUNG DER DURCH MUTIERTES p53 VERURSACHTEN MODULATION VON DNA Download PDF

Info

Publication number
WO1999037803A3
WO1999037803A3 PCT/DE1999/000221 DE9900221W WO9937803A3 WO 1999037803 A3 WO1999037803 A3 WO 1999037803A3 DE 9900221 W DE9900221 W DE 9900221W WO 9937803 A3 WO9937803 A3 WO 9937803A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhibition
mutated
modulation caused
dna
dna modulation
Prior art date
Application number
PCT/DE1999/000221
Other languages
English (en)
French (fr)
Other versions
WO1999037803A9 (de
WO1999037803A2 (de
Inventor
Wolfgang W Deppert
Original Assignee
Wolfgang W Deppert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to PL99342399A priority Critical patent/PL342399A1/xx
Priority to CA002318313A priority patent/CA2318313A1/en
Priority to SK1105-2000A priority patent/SK11052000A3/sk
Priority to BR9907725-6A priority patent/BR9907725A/pt
Priority to DE19980080T priority patent/DE19980080D2/de
Priority to JP2000528710A priority patent/JP2002507389A/ja
Application filed by Wolfgang W Deppert filed Critical Wolfgang W Deppert
Priority to AU29200/99A priority patent/AU755775B2/en
Priority to EP99910089A priority patent/EP1049810A2/de
Publication of WO1999037803A2 publication Critical patent/WO1999037803A2/de
Publication of WO1999037803A3 publication Critical patent/WO1999037803A3/de
Publication of WO1999037803A9 publication Critical patent/WO1999037803A9/de
Priority to NO20003762A priority patent/NO20003762L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Die vorliegende Erfindung betrifft ein Verfahren zur Hemmung von durch mut p53 verursachten Modulation von DNA, umfassend die Inhibierung der Bindung von mut p53 an DNA mit Strangtrennungspotential. Ferner betrifft die Erfindung ein System zur Identifizierung von Substanzen, die sich zu einer solchen Hemmung eignen.
PCT/DE1999/000221 1998-01-26 1999-01-22 HEMMUNG DER DURCH MUTIERTES p53 VERURSACHTEN MODULATION VON DNA WO1999037803A2 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA002318313A CA2318313A1 (en) 1998-01-26 1999-01-22 Inhibition of dna modulation caused by mutated p53
SK1105-2000A SK11052000A3 (sk) 1998-01-26 1999-01-22 Inhibícia modulácie dna spôsobenej mutovaným p53
BR9907725-6A BR9907725A (pt) 1998-01-26 1999-01-22 Inibição de modulação de dna provocada por p53 mutado
DE19980080T DE19980080D2 (de) 1998-01-26 1999-01-22 Hemmung der durch mutiertes p53 verursachten Modulation von DNA
JP2000528710A JP2002507389A (ja) 1998-01-26 1999-01-22 変異ｐ５３によって引き起こされるＤＮＡモジュレーションの阻害
PL99342399A PL342399A1 (en) 1998-01-26 1999-01-22 Inhibition of dna modulation caused by mutated p53
AU29200/99A AU755775B2 (en) 1998-01-26 1999-01-22 Inhibition of DNA modulation caused by mutated p53
EP99910089A EP1049810A2 (de) 1998-01-26 1999-01-22 HEMMUNG DER DURCH MUTIERTES p53 VERURSACHTEN MODULATION VON DNA
NO20003762A NO20003762L (no) 1998-01-26 2000-07-21 Inhibering av DNA-modulering forÕrsaket av mutert p53

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802792A DE19802792A1 (de) 1998-01-26 1998-01-26 Hemmung der durch mutiertes p53 verursachten Modulation von DNA
DE19802792.3 1998-01-26

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/890,433 Continuation US20050070495A1 (en) 1998-01-26 2003-04-22 Inhibition of DNA modulation caused by mutated p53

Publications (3)

Publication Number Publication Date
WO1999037803A2 WO1999037803A2 (de) 1999-07-29
WO1999037803A3 true WO1999037803A3 (de) 1999-10-14
WO1999037803A9 WO1999037803A9 (de) 1999-11-18

Family

ID=7855657

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/000221 WO1999037803A2 (de) 1998-01-26 1999-01-22 HEMMUNG DER DURCH MUTIERTES p53 VERURSACHTEN MODULATION VON DNA

Country Status (13)

Country Link
EP (1) EP1049810A2 (de)
JP (1) JP2002507389A (de)
KR (1) KR100413929B1 (de)
CN (1) CN1289373A (de)
AU (1) AU755775B2 (de)
BR (1) BR9907725A (de)
CA (1) CA2318313A1 (de)
DE (2) DE19802792A1 (de)
NO (1) NO20003762L (de)
PL (1) PL342399A1 (de)
RU (1) RU2235786C2 (de)
SK (1) SK11052000A3 (de)
WO (1) WO1999037803A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100348113C (zh) * 2005-05-14 2007-11-14 章建庆 一种食用籼草鱼的制作方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014794A1 (en) * 1995-10-20 1997-04-24 University Of Dundee ACTIVATION OF p53 PROTEIN

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224784D0 (en) * 1992-11-26 1993-01-13 Univ Dundee Cellular protein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014794A1 (en) * 1995-10-20 1997-04-24 University Of Dundee ACTIVATION OF p53 PROTEIN

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ABARZUA P ET AL: "MICROINJECTION OF MONOCLONAL ANTIBODY PAB421 INTO HUMAN SW480 COLORECTAL CARCINOMA CELLS RESTORES THE TRANSCRIPTION ACTIVATION FUNCTION TO MUTANT P53", CANCER RESEARCH, vol. 55, 15 August 1995 (1995-08-15), pages 3490 - 3494, XP002035503, ISSN: 0008-5472 *
BODE ET AL.: "BIOLOGICAL SIGNIFICANCE OF UNWINDING CAPABILITY OF NUCLEAR MATRIX-ASSOCIATING DNAs", SCIENCE, 1992, pages 195 - 197, XP002110938 *
DU ET AL.: "MODULAR STRUCTURAL ELEMENTS IN THE REPLICATION ORIGIN REGION OF TETRAHYMENA rDNA", NUCLEIC ACIDS RESEARCH, vol. 23, no. 10, 1995, pages 1766 - 1774, XP002110939 *
GANNON J V ET AL: "ACTIVATING MUTATIONS IN P53 PRODUCE A COMMON CONFORMATIONAL EFFECT.A MONOCLONAL ANTIBODY SPECIFIC FOR THE MUTANT FORM", EMBO JOURNAL, vol. 9, no. 5, 1 March 1990 (1990-03-01), pages 1595 - 1602, XP000676347, ISSN: 0261-4189 *
JANNOT C B ET AL: "CHARACTERIZATION OF SCFV-421, A SINGLE-CHAIN ANTIBODY TARGETED TO P53", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 230, no. 2, 13 January 1997 (1997-01-13), pages 242 - 246, XP002035502, ISSN: 0006-291X *
MÜLLER ET AL.: "SPECIFIC BINDING OF MAR/SAR DNA-ELEMENTS", ONCOGENE, vol. 12, 1996, pages 1941 - 1952, XP002110937 *
WEISSKER ET AL.: "SPECIFIC AND COMPLEX INTERACTIONS OF MURINE p53 WITH DNA", ONCOGENE, vol. 7, 1992, pages 1921 - 1932, XP002110940 *

Also Published As

Publication number Publication date
DE19802792A1 (de) 1999-07-29
CN1289373A (zh) 2001-03-28
SK11052000A3 (sk) 2001-05-10
JP2002507389A (ja) 2002-03-12
CA2318313A1 (en) 1999-07-29
WO1999037803A9 (de) 1999-11-18
AU755775B2 (en) 2002-12-19
AU2920099A (en) 1999-08-09
RU2235786C2 (ru) 2004-09-10
DE19980080D2 (de) 2001-03-29
PL342399A1 (en) 2001-06-04
NO20003762D0 (no) 2000-07-21
NO20003762L (no) 2000-07-21
EP1049810A2 (de) 2000-11-08
KR100413929B1 (ko) 2004-01-07
BR9907725A (pt) 2001-09-04
KR20010040407A (ko) 2001-05-15
WO1999037803A2 (de) 1999-07-29

Similar Documents

Publication Publication Date Title
AU5041499A (en) Method for making paper, assembly for implementing the method and paper product produced by the method
ZA991289B (en) Guidance system for an automated guided-vehicle.
AU5439899A (en) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors
AU3376897A (en) Microfluidic method for nucleic acid amplification
ZA981466B (en) Method for determining a nucleic acid.
AU7285698A (en) Automated, quantitative filtration of liquids
AU4700699A (en) Nucleotide detection method
DE69727963D1 (de) Verfahren zur kristallisation von 2,4,6,8,10,12,-hexanitro-2,4,6,8,10,12,-hexaazatetrazyklo- [5.5.0.05,9 0 3,11]-dodecan durch ausfällen
AU2552899A (en) Method for collecting information about traffic situations
AU3977399A (en) Bi-cell separation for improved safety
HK1050528A1 (en) Method for separating analogous organic compounds.
HK1038007A1 (en) Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline.
SG71918A1 (en) Method for the separation of a first liquid from a second one
WO2002057783A3 (en) Method of screening for gpr40 ligands
ZA99493B (en) Method for the isolation of nucleic acid.
AU2496197A (en) Method for the detection of creatinine
AU1930799A (en) Method for a vehicular gateway to transport information, including a method for programming the gateway
AU7424600A (en) Method for acquiring a certain product, such as a car, through the internet
AUPP101297A0 (en) Separators for oil, gas, mud and solids
AU6609298A (en) Dual tube system, method and tools for the production thereof
WO2001046686A3 (de) Chromatographiematerial und verfahren unter verwendung desselben
WO1999037803A3 (de) HEMMUNG DER DURCH MUTIERTES p53 VERURSACHTEN MODULATION VON DNA
GC0000007A (en) Process for separating linear internal olefins from branched internal olefins.
AU1232599A (en) Method for separating an organic compound from an aqueous medium
AU4607699A (en) Method for isolating polymers from solutions

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99802374.4

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/3-3/3, DRAWINGS, REPLACED BY NEW PAGES 1/3-3/3; AFTER RECTIFICATION OF OBVIOUS ERRORS AS AUTHORIZED BY THE INTERNATIONAL SEARCHING AUTHORITY

ENP Entry into the national phase

Ref document number: 2318313

Country of ref document: CA

Ref document number: 2318313

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1999910089

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11052000

Country of ref document: SK

WWE Wipo information: entry into national phase

Ref document number: PV2000-2714

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 1020007008117

Country of ref document: KR

Ref document number: 29200/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/007319

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 09600981

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999910089

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV2000-2714

Country of ref document: CZ

REF Corresponds to

Ref document number: 19980080

Country of ref document: DE

Date of ref document: 20010329

WWE Wipo information: entry into national phase

Ref document number: 19980080

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 1020007008117

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 29200/99

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1020007008117

Country of ref document: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8607

WWW Wipo information: withdrawn in national office

Ref document number: 1999910089

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV2000-2714

Country of ref document: CZ